Glass House Brands Announces Uplist to NYSE
June 25, 2026
Health
-
-
QScreen AI Announces Close of First Tranche of Private Placement
June 25, 2026
-
Fortitude and HeartSciences (Nasdaq: HSCS) Announce Business Combination, Aiming to Bring a Leading Vertically-Integrated Zcash Mining Platform to the Public Markets
June 23, 2026
-
BrainsWay Reports Favorable Coverage for Accelerated Deep TMS(TM) Rises to Over 57 Million Covered Lives
June 22, 2026
-
LifeMD Announces Exclusive Collaboration to Launch Direct-to-Patient Self-Pay Program for XYOSTED® (testosterone enanthate) Injection
June 22, 2026
-
Chicago Atlantic Real Estate Finance, Inc. and Chicago Atlantic BDC, Inc. Announce Definitive Merger Agreement
June 18, 2026
-
Hyperfine Swoop® System Scan Volume in the United States Hits Record Milestones Across Multiple Sites of Care
June 18, 2026
-
VolitionRx Announces Collaboration with Sysmex
June 17, 2026
-
Sanuwave Health Updates Second Quarter 2026 Guidance
June 16, 2026
-
Aclarion Partners with PRIA Healthcare to Advance Reimbursement and Commercial Adoption of Its AI-Powered Nociscan Platform
June 9, 2026
-
Neurogene Announces Successful Completion of Dosing in Embolden(TM) Registrational Trial of NGN-401 for Rett Syndrome
June 8, 2026
-
Standard BioTools and Treeline Biosciences Announce Merger Agreement
June 8, 2026
-
Nuwellis Announces Pricing of $6 Million Public Offering
June 5, 2026
-
Trulieve Announces Uplist to NYSE
June 5, 2026
-
Lifecore Biomedical Signs Agreement with New Biopharmaceutical Customer
June 2, 2026
-
HeartBeam Announces New Peer-Reviewed Article Demonstrating Potential to Help Identify Heart Attack Risk at Home
June 2, 2026